 |
25 Diseases |  |
17 Trials |
|
17 Trials |  |
675 News |  |
| «12345678910 |
- | buprenorphine transdermal / Generic mfg.
New P1 trial: Clinical Pilot Study in Healthy Men to Characterize the Uptake of Buprenorphine Into and Its Elimination From the Body After Topical Application of Two New Forms of a Skin Patch in Comparison to a Reference Patch (clinicaltrials.gov) - Dec 23, 2018
P1, N=47, Completed, Sponsor: Gr
- | Sublocade (buprenorphine once-monthly depot) / Indivior
New P4 trial: Buprenorphine vs Buprenorphine/Naloxone on the Effects of Maternal Symptomatology (clinicaltrials.gov) - Nov 14, 2018
P4, N=144, Recruiting, Sponsor: Stony Brook University
- | buprenorphine transdermal / Generic mfg.
New P2/3 trial: Buprenorphine Transdermal Patches in Arthroscopic Rotator Cuff Repair (clinicaltrials.gov) - Dec 21, 2017
P2/3, N=50, Recruiting, Sponsor: Hospital Italiano de Buenos Aires
- | tramadol hydrochloride / Generic mfg.
Trial completion, Trial primary completion date, HEOR, Surgery: Postoperative Analgesia With Buprenorphine for Postoperative Pain Control and Quality of Life After Spinal Surgery (clinicaltrials.gov) - May 3, 2017
P4, N=69, Completed, Sponsor: Seoul National University Hospital
Recruiting --> Completed | Trial primary completion date: Nov 2016 --> Jul 2016
- | buprenorphine transdermal / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date: DEP-PAIN-DEM: Efficacy of Pain Treatment on Depression in Patients With Dementia (clinicaltrials.gov) - Apr 4, 2017
P4, N=163, Completed, Sponsor: University of Bergen
Recruiting --> Completed | Trial primary completion date: Nov 2016 --> Jul 2016 Recruiting --> Completed | N=266 --> 163 | Trial primary completion date: Jun 2015 --> Dec 2016
- || buprenorphine transdermal / Generic mfg.
Trial completion: Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children (clinicaltrials.gov) - May 24, 2016
P3, N=41, Completed, Sponsor: Purdue Pharma LP
Recruiting --> Completed | N=266 --> 163 | Trial primary completion date: Jun 2015 --> Dec 2016 Active, not recruiting --> Completed
- tramadol hydrochloride / Generic mfg.
Trial primary completion date, HEOR, Surgery: Postoperative Analgesia With Buprenorphine for Postoperative Pain Control and Quality of Life After Spinal Surgery (clinicaltrials.gov) - Apr 14, 2016
P4, N=76, Recruiting, Sponsor: Seoul National University Hospital
Active, not recruiting --> Completed Trial primary completion date: Nov 2015 --> Nov 2016
- | buprenorphine transdermal / Generic mfg.
Enrollment closed: Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children (clinicaltrials.gov) - Nov 11, 2015
P3, N=40, Active, not recruiting, Sponsor: Purdue Pharma LP
Trial primary completion date: Nov 2015 --> Nov 2016 Recruiting --> Active, not recruiting
- | buprenorphine transdermal / Generic mfg.
New P4 trial: Efficacy and Safety of Buprenorphine Transdermal Patch in Non-cancer Pain of Moderate Intensity (clinicaltrials.gov) - Aug 10, 2015
P4, N=78, Completed, Sponsor: Mundipharma Pharmaceuticals Sdn. Bhd.
- tramadol/acetaminophen / Generic mfg., buprenorphine transdermal / Generic mfg.
Trial completion, Surgery: Compare the Efficacy and Safety of Norspan to Tramadol/Acetaminophen With Prolonged Postoperative Pain (PASSION) (clinicaltrials.gov) - Jul 9, 2015
P4, N=136, Completed, Sponsor: Mundipharma Korea Ltd
Recruiting --> Active, not recruiting Recruiting --> Completed
- | buprenorphine transdermal / Generic mfg.
Trial primary completion date: Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children (clinicaltrials.gov) - Jun 11, 2015
P3, N=40, Recruiting, Sponsor: Purdue Pharma LP
Recruiting --> Completed Trial primary completion date: May 2015 --> Apr 2016
- buprenorphine transdermal / Generic mfg.
Trial completion, Trial primary completion date: Strength Training Study for Survivors of Breast and Gynecologic Cancer (clinicaltrials.gov) - Jun 6, 2015
P=N/A, N=20, Completed, Sponsor: Nova Scotia Health Authority
Trial primary completion date: May 2015 --> Apr 2016 Recruiting --> Completed | Trial primary completion date: May 2013 --> Jan 2015
- ||||| tramadol hydrochloride / Generic mfg.
New P4 trial, HEOR, Surgery: Postoperative Analgesia With Buprenorphine for Postoperative Pain Control and Quality of Life After Spinal Surgery (clinicaltrials.gov) - Apr 15, 2015
P4, N=76, Recruiting, Sponsor: Seoul National University Hospital
- |||| buprenorphine transdermal / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date: Evaluation Of Efficacy And Safety Of Norspan In Moderate To Severe Pain Due To Osteoarthritis, Rheumatoid Arthritis, Joint/Muscle Pain (clinicaltrials.gov) - Jan 15, 2015
P4, N=119, Completed, Sponsor: Mundipharma Pte Ltd.
Recruiting --> Completed | Trial primary completion date: May 2013 --> Jan 2015 Recruiting --> Completed | N=230 --> 119 | Trial primary completion date: Aug 2014 --> Jan 2015
- buprenorphine transdermal / Generic mfg.
Enrollment change, Trial withdrawal: Butrans for Treatment of Restless Legs Syndrome (clinicaltrials.gov) - Jan 7, 2015
P4, N=0, Withdrawn, Sponsor: Massachusetts General Hospital
Recruiting --> Completed | N=230 --> 119 | Trial primary completion date: Aug 2014 --> Jan 2015 N=20 --> 0 | Not yet recruiting --> Withdrawn
- |||| oxycodone controlled release / Generic mfg., buprenorphine transdermal / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date: Norspan Versus Oxycontin as Postoperative Painkiller to Proximal Extracapsular Fractures of the Femur (clinicaltrials.gov) - Dec 9, 2014
P4, N=76, Completed, Sponsor: Vejle Hospital
N=20 --> 0 | Not yet recruiting --> Withdrawn Recruiting --> Completed | N=50 --> 76 | Trial primary completion date: Sep 2013 --> May 2013
- | buprenorphine transdermal / Generic mfg.
New P4 trial: DEP-PAIN-DEM: Efficacy of Pain Treatment on Depression in Patients With Dementia (clinicaltrials.gov) - Oct 17, 2014
P4, N=266, Recruiting, Sponsor: University of Bergen
- | buprenorphine transdermal / Generic mfg.
Trial completion: A Dose Proportionality and Bioavailability Assessment of Buprenorphine Transdermal Delivery System Second Generation Patches (clinicaltrials.gov) - Sep 30, 2014
P1, N=20, Completed, Sponsor: Mundipharma Research Limited
Recruiting --> Completed | N=50 --> 76 | Trial primary completion date: Sep 2013 --> May 2013 Recruiting --> Completed
- buprenorphine transdermal / Generic mfg.
Enrollment open: A Dose Proportionality and Bioavailability Assessment of Buprenorphine Transdermal Delivery System Second Generation Patches (clinicaltrials.gov) - Jun 8, 2014
P1, N=20, Recruiting, Sponsor: Mundipharma Research Limited
Recruiting --> Completed Not yet recruiting --> Recruiting
- | buprenorphine transdermal / Generic mfg.
New P1 trial: A Dose Proportionality and Bioavailability Assessment of Buprenorphine Transdermal Delivery System Second Generation Patches (clinicaltrials.gov) - Jun 3, 2014
P1, N=20, Recruiting, Sponsor: Mundipharma Research Limited
- | buprenorphine transdermal / Generic mfg.
Trial primary completion date: Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children (clinicaltrials.gov) - May 21, 2014
P3, N=40, Recruiting, Sponsor: Purdue Pharma LP
Not yet recruiting --> Recruiting Trial primary completion date: Aug 2014 --> May 2015
- buprenorphine transdermal / Generic mfg.
Trial completion date: Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children (clinicaltrials.gov) - May 21, 2014
P3, N=40, Recruiting, Sponsor: Purdue Pharma LP
Trial primary completion date: Aug 2014 --> May 2015 Trial completion date: Aug 2014 --> Jun 2015
- buprenorphine transdermal / Generic mfg.
New P4 trial: Butrans for Treatment of Restless Legs Syndrome (clinicaltrials.gov) - May 12, 2014
P4, N=20, Not yet recruiting, Sponsor: Massachusetts General Hospital
- ||| naltrexone / Generic mfg.
New P1 trial: The Effect of Buprenorphine Delivered by Buprenorphine Transdermal System (BTDS) at Doses up to 80 Micrograms/Hour (mcg/hr) and Naltrexone on Electrocardiogram (ECG) Intervals in Healthy Volunteers (clinicaltrials.gov) - Dec 1, 2013
P1, N=328, Completed, Sponsor: Purdue Pharma LP
- ||||| tramadol/acetaminophen / Generic mfg., buprenorphine transdermal / Generic mfg.
New P4 trial, Surgery: Compare the Efficacy and Safety of Norspan to Tramadol/Acetaminophen With Prolonged Postoperative Pain (PASSION) (clinicaltrials.gov) - Nov 11, 2013
P4, N=130, Recruiting, Sponsor: Mundipharma Korea Ltd
- |||| tramadol/acetaminophen / Generic mfg., buprenorphine transdermal / Generic mfg.
Enrollment open, Surgery: Compare the Efficacy and Safety of Norspan to Tramadol/Acetaminophen With Prolonged Postoperative Pain (PASSION) (clinicaltrials.gov) - Nov 4, 2013
P4, N=130, Recruiting, Sponsor: Mundipharma Korea Ltd
Trial completion date: Aug 2014 --> Jun 2015 Not yet recruiting --> Recruiting
- ||||| buprenorphine transdermal / Generic mfg.
New P4 trial: Evaluation Of Efficacy And Safety Of Norspan In Moderate To Severe Pain Due To Osteoarthritis, Rheumatoid Arthritis, Joint/Muscle Pain (clinicaltrials.gov) - Oct 9, 2013
P4, N=230, Recruiting, Sponsor: Mundipharma Pte Ltd.
- buprenorphine transdermal / Generic mfg.
Enrollment closed: An Interventional Study to Assess the Efficacy and Safety of Buprenorphine in Korean Patients With Spinal Disorders (clinicaltrials.gov) - Aug 4, 2013
P4, N=242, Active, not recruiting, Sponsor: Mundipharma
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- | buprenorphine transdermal / Generic mfg.
New P4 trial: An Interventional Study to Assess the Efficacy and Safety of Buprenorphine in Korean Patients With Spinal Disorders (clinicaltrials.gov) - Mar 24, 2013
P4, N=242, Active, not recruiting, Sponsor: Mundipharma
- | buprenorphine transdermal / Generic mfg.
Enrollment change: Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children (clinicaltrials.gov) - Feb 7, 2013
P3, N=40, Recruiting, Sponsor: Purdue Pharma LP
Recruiting --> Active, not recruiting N=30 --> 40
- buprenorphine transdermal / Generic mfg.
Enrollment open: Strength Training Study for Survivors of Breast and Gynecologic Cancer (clinicaltrials.gov) - Nov 26, 2012
P=N/A, N=20, Recruiting, Sponsor: Capital District Health Authority, Canada
N=30 --> 40 Not yet recruiting --> Recruiting
- buprenorphine transdermal / Generic mfg.
Trial completion: Investigation of Analgesic and Anti-hyperalgesic Effect of Opioids in Experimental Pain (clinicaltrials.gov) - Sep 12, 2012
P3, N=22, Completed, Sponsor: University of Aarhus
Not yet recruiting --> Recruiting Recruiting --> Completed
- |||| buprenorphine transdermal / Generic mfg.
Trial completion: Norspan Efficacy and Safety Among Elderly Subjects (clinicaltrials.gov) - Aug 7, 2012
P4, N=102, Completed, Sponsor: Mundipharma AB
Recruiting --> Completed Recruiting --> Completed
- | buprenorphine transdermal / Generic mfg.
New P1 trial: Norspan Transdermal Patches Study in Osteoarthritis Patients (clinicaltrials.gov) - Jul 16, 2012
P1, N=30, Completed, Sponsor: Mundipharma Pte Ltd.
- || buprenorphine transdermal / Generic mfg.
New P3 trial: NORSPAN Transdermal Patches Phase III Study In Non-Cancer Pain (clinicaltrials.gov) - Nov 20, 2011
P3, N=280, Completed, Sponsor: Mundipharma